CTXR Citius Pharmaceuticals, Inc.
$0.50▲ +11.62%
Healthcare
Other
After hours
$0.52▲ +3.67%
Oct 27, 4:57 PM ET
Volume 521.7K
Avg Volume (10D) 311.5K
Key Metrics & Fundamentals
Market Cap
$13.77M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.37 - 1.67
% vs 50 MA
-6.97%
% vs 200 MA
-24.22%
RSI-14
52.7
MACD Histogram
+0.0000
Beta (1Y vs SPY)
2.59
Free Cash Flow
-$8.68M
Gross Rev
$1.49M
Gross Profit
$1.00M
EBITDA
-$10.03M
COGS
$491,843
Operating Exp
$11.01M
Operating Income
-$10.01M
EBIT
-$10.01M
Pretax Income
-$12.03M
Net Income
-$8.86M
EPS (Diluted)
-0.34
Price & Volume History
Loading chart…
Recent News
Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
PR Newswire · Oct 26, 2026 1:00 PM ET
Citius Pharmaceuticals to Participate in October 2026 Investor Conferences
PR Newswire · Oct 12, 2026 8:30 AM ET
Citius Pharmaceuticals to Participate in September 2026 Investor Conferences
PR Newswire · Sep 3, 2026 8:30 AM ET
Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
PR Newswire · Aug 14, 2026 4:30 PM ET
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
PR Newswire · Aug 14, 2026 4:30 PM ET
Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri
PR Newswire · Aug 12, 2026 8:00 AM ET
Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment
PR Newswire · Aug 5, 2026 9:17 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CTXR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.